ScreenerHero

BUX Biomark Diagnostics Inc.

CNQ · CA · Healthcare · Diagnostics & Research · biomarkdiagnostics.com
0.5200CAD-5.45%Mkt Cap: 40.32M $P/E: —

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of l…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$244.79BUSDP/E 36.7
DHR
Danaher Corporation
$153.60BUSDP/E 38.9
NTRA
Natera, Inc.
$57.02BUSD
LONN
Lonza Group AG
$46.01BUSDP/E 38.3
A
Agilent Technologies, Inc.
$47.67BUSDP/E 33.4
WAT
Waters Corporation
$42.81BUSDP/E 110.4
IQV
IQVIA Holdings Inc.
$42.48BUSDP/E 32.1
ILMN
Illumina, Inc.
$40.43BUSDP/E 50.0
IDXX
IDEXX Laboratories, Inc.
$39.97BUSDP/E 35.6
MTD
Mettler-Toledo International Inc.
$30.73BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.30BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.1
GH
Guardant Health, Inc.
$22.59BUSD
RVTY
Revvity, Inc.
$17.14BUSDP/E 73.5
MEDP
Medpace Holdings, Inc.
$16.87BUSDP/E 35.5
ERF
Eurofins Scientific SE
$14.23BUSDP/E 26.6
CRL
Charles River Laboratories International, Inc.
$14.34BUSD
ICLR
ICON Public Limited Company
$12.66BUSDP/E 172.7
BIM
bioMérieux S.A.
$10.35BUSDP/E 20.7
QGEN
Qiagen N.V.
$9.25BUSDP/E 22.7

Key Statistics

Company
Market Cap40.32M USD
Enterprise Value43.00M USD
Revenue (TTM)20.25K USD
Gross Profit20.25K USD
Net Income (TTM)-1.08M USD
Revenue/Share0.00 CAD
Last Price0.5200 CAD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISINCA09073K1084
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-33.85
EV/Revenue2123.83
P/S2106.46
P/B110.00
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.270068% of range0.6400
52W High0.6400 CAD
52W Low0.2700 CAD
Profitability
Gross Margin100.00%
Oper. Margin-5909.89%
EBITDA Margin0.00%
Profit Margin-2470.76%
ROE-446.20%
ROA-79.40%
Growth
Revenue Growth-82.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-792.92K USD
CapEx (TTM)3.08K USD
FCF Margin-2188.96%
FCF Yield-1.10%
Net Debt351.68K USD
Net Debt/EBITDA-0.28
Balance Sheet
Debt/Equity2.19
Current Ratio1.29
Quick Ratio1.26
Book Value/Sh0.0050 CAD
Cash/Share0.0070 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.106.48M
Float48.98M
Insiders48.49%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short261
Short (prev mo.)879
Technical
SMA 500.5254 (-1.0%)
SMA 2000.5474 (-5.0%)
Beta-0.38
S&P 52W Chg16.45%
Avg Vol (30d)5.51K
Avg Vol (10d)5.65K
Technical Indicators
RSI (14)40.9
MACD-0.0034
MACD Signal-0.0034
MACD Hist.+0.0001
BB Upper0.5774 CAD
BB Middle0.5435 CAD
BB Lower0.5096 CAD
BB Width12.47%
ATR (14)0.0178 CAD
Vol Ratio (20d)0.12x